nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—systemic lupus erythematosus	0.583	1	CiPCiCtD
Atazanavir—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.061	0.199	CbGbCtD
Atazanavir—ABCC1—Cyclosporine—systemic lupus erythematosus	0.032	0.105	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.0245	0.08	CbGbCtD
Atazanavir—CYP2C9—Leflunomide—systemic lupus erythematosus	0.017	0.0555	CbGbCtD
Atazanavir—ABCC1—Methotrexate—systemic lupus erythematosus	0.0169	0.0553	CbGbCtD
Atazanavir—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0134	0.0439	CbGbCtD
Atazanavir—CYP2C9—Dapsone—systemic lupus erythematosus	0.0121	0.0395	CbGbCtD
Atazanavir—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0102	0.0333	CbGbCtD
Atazanavir—ABCB1—Betamethasone—systemic lupus erythematosus	0.00873	0.0286	CbGbCtD
Atazanavir—ABCB1—Prednisolone—systemic lupus erythematosus	0.00861	0.0282	CbGbCtD
Atazanavir—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00816	0.0267	CbGbCtD
Atazanavir—ABCB1—Prednisone—systemic lupus erythematosus	0.00813	0.0266	CbGbCtD
Atazanavir—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00804	0.0263	CbGbCtD
Atazanavir—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00794	0.026	CbGbCtD
Atazanavir—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00771	0.0252	CbGbCtD
Atazanavir—CYP3A4—Dapsone—systemic lupus erythematosus	0.00703	0.023	CbGbCtD
Atazanavir—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0061	0.0199	CbGbCtD
Atazanavir—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0061	0.0199	CbGbCtD
Atazanavir—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00523	0.0171	CbGbCtD
Atazanavir—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00523	0.0171	CbGbCtD
Atazanavir—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00516	0.0169	CbGbCtD
Atazanavir—CYP2C9—cardial valve—systemic lupus erythematosus	0.00511	0.453	CbGeAlD
Atazanavir—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00508	0.0166	CbGbCtD
Atazanavir—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00489	0.016	CbGbCtD
Atazanavir—CYP3A4—Prednisone—systemic lupus erythematosus	0.00487	0.0159	CbGbCtD
Atazanavir—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00462	0.0151	CbGbCtD
Atazanavir—ABCB1—Methotrexate—systemic lupus erythematosus	0.00408	0.0133	CbGbCtD
Atazanavir—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00304	0.00995	CbGbCtD
Atazanavir—CYP2C9—urine—systemic lupus erythematosus	0.0011	0.0978	CbGeAlD
Atazanavir—CYP3A4—urine—systemic lupus erythematosus	0.00084	0.0746	CbGeAlD
Atazanavir—SLCO1B3—lung—systemic lupus erythematosus	0.000632	0.0561	CbGeAlD
Atazanavir—CYP2C9—blood plasma—systemic lupus erythematosus	0.000575	0.051	CbGeAlD
Atazanavir—CYP3A4—blood plasma—systemic lupus erythematosus	0.000438	0.0389	CbGeAlD
Atazanavir—ABCC1—cortex of kidney—systemic lupus erythematosus	0.000335	0.0298	CbGeAlD
Atazanavir—ABCB1—blood plasma—systemic lupus erythematosus	0.00031	0.0275	CbGeAlD
Atazanavir—ABCC1—tendon—systemic lupus erythematosus	0.000278	0.0247	CbGeAlD
Atazanavir—ABCC1—lung—systemic lupus erythematosus	0.000244	0.0217	CbGeAlD
Atazanavir—CYP3A4—kidney—systemic lupus erythematosus	0.000199	0.0176	CbGeAlD
Atazanavir—ABCB1—nephron tubule—systemic lupus erythematosus	0.00016	0.0142	CbGeAlD
Atazanavir—ABCB1—kidney—systemic lupus erythematosus	0.000141	0.0125	CbGeAlD
Atazanavir—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000137	0.0122	CbGeAlD
Atazanavir—CYP3A4—nervous system—systemic lupus erythematosus	0.00013	0.0116	CbGeAlD
Atazanavir—CYP3A4—central nervous system—systemic lupus erythematosus	0.000126	0.0111	CbGeAlD
Atazanavir—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000121	0.0107	CbGeAlD
Atazanavir—ABCB1—bone marrow—systemic lupus erythematosus	0.00011	0.00976	CbGeAlD
Atazanavir—ABCB1—lung—systemic lupus erythematosus	9.96e-05	0.00884	CbGeAlD
Atazanavir—ABCB1—nervous system—systemic lupus erythematosus	9.23e-05	0.00819	CbGeAlD
Atazanavir—ABCB1—central nervous system—systemic lupus erythematosus	8.88e-05	0.00789	CbGeAlD
Atazanavir—Hypertension—Dexamethasone—systemic lupus erythematosus	4.74e-05	0.000474	CcSEcCtD
Atazanavir—Hypertension—Betamethasone—systemic lupus erythematosus	4.74e-05	0.000474	CcSEcCtD
Atazanavir—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.71e-05	0.000471	CcSEcCtD
Atazanavir—Urticaria—Cyclosporine—systemic lupus erythematosus	4.69e-05	0.000469	CcSEcCtD
Atazanavir—Myalgia—Dexamethasone—systemic lupus erythematosus	4.67e-05	0.000467	CcSEcCtD
Atazanavir—Myalgia—Betamethasone—systemic lupus erythematosus	4.67e-05	0.000467	CcSEcCtD
Atazanavir—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.66e-05	0.000467	CcSEcCtD
Atazanavir—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.66e-05	0.000467	CcSEcCtD
Atazanavir—Anxiety—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.000466	CcSEcCtD
Atazanavir—Anxiety—Betamethasone—systemic lupus erythematosus	4.66e-05	0.000466	CcSEcCtD
Atazanavir—Discomfort—Betamethasone—systemic lupus erythematosus	4.62e-05	0.000462	CcSEcCtD
Atazanavir—Discomfort—Dexamethasone—systemic lupus erythematosus	4.62e-05	0.000462	CcSEcCtD
Atazanavir—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.62e-05	0.000462	CcSEcCtD
Atazanavir—Pain—Prednisolone—systemic lupus erythematosus	4.59e-05	0.000459	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000459	CcSEcCtD
Atazanavir—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.57e-05	0.000457	CcSEcCtD
Atazanavir—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.56e-05	0.000456	CcSEcCtD
Atazanavir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.55e-05	0.000455	CcSEcCtD
Atazanavir—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.55e-05	0.000455	CcSEcCtD
Atazanavir—Nausea—Leflunomide—systemic lupus erythematosus	4.54e-05	0.000454	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000453	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.53e-05	0.000453	CcSEcCtD
Atazanavir—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.52e-05	0.000452	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.5e-05	0.00045	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.5e-05	0.00045	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.49e-05	0.000449	CcSEcCtD
Atazanavir—Pain—Hydrocortisone—systemic lupus erythematosus	4.48e-05	0.000449	CcSEcCtD
Atazanavir—Oedema—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000448	CcSEcCtD
Atazanavir—Oedema—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000448	CcSEcCtD
Atazanavir—Insomnia—Triamcinolone—systemic lupus erythematosus	4.47e-05	0.000447	CcSEcCtD
Atazanavir—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.46e-05	0.000446	CcSEcCtD
Atazanavir—Infection—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000445	CcSEcCtD
Atazanavir—Infection—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000445	CcSEcCtD
Atazanavir—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.44e-05	0.000444	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.42e-05	0.000443	CcSEcCtD
Atazanavir—Shock—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000441	CcSEcCtD
Atazanavir—Shock—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000441	CcSEcCtD
Atazanavir—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.4e-05	0.00044	CcSEcCtD
Atazanavir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.39e-05	0.000439	CcSEcCtD
Atazanavir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.39e-05	0.000439	CcSEcCtD
Atazanavir—Agitation—Prednisone—systemic lupus erythematosus	4.39e-05	0.000439	CcSEcCtD
Atazanavir—Angioedema—Prednisone—systemic lupus erythematosus	4.37e-05	0.000437	CcSEcCtD
Atazanavir—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.35e-05	0.000435	CcSEcCtD
Atazanavir—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.35e-05	0.000435	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000434	CcSEcCtD
Atazanavir—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.34e-05	0.000434	CcSEcCtD
Atazanavir—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.33e-05	0.000433	CcSEcCtD
Atazanavir—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.33e-05	0.000433	CcSEcCtD
Atazanavir—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.32e-05	0.000432	CcSEcCtD
Atazanavir—Malaise—Prednisone—systemic lupus erythematosus	4.31e-05	0.000431	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000429	CcSEcCtD
Atazanavir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.29e-05	0.000429	CcSEcCtD
Atazanavir—Syncope—Prednisone—systemic lupus erythematosus	4.29e-05	0.000429	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000428	CcSEcCtD
Atazanavir—Anorexia—Dexamethasone—systemic lupus erythematosus	4.27e-05	0.000427	CcSEcCtD
Atazanavir—Anorexia—Betamethasone—systemic lupus erythematosus	4.27e-05	0.000427	CcSEcCtD
Atazanavir—Urticaria—Prednisolone—systemic lupus erythematosus	4.27e-05	0.000427	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000426	CcSEcCtD
Atazanavir—Fatigue—Triamcinolone—systemic lupus erythematosus	4.26e-05	0.000426	CcSEcCtD
Atazanavir—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.25e-05	0.000425	CcSEcCtD
Atazanavir—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.000424	CcSEcCtD
Atazanavir—Asthenia—Cyclosporine—systemic lupus erythematosus	4.23e-05	0.000423	CcSEcCtD
Atazanavir—Pain—Triamcinolone—systemic lupus erythematosus	4.22e-05	0.000422	CcSEcCtD
Atazanavir—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.2e-05	0.00042	CcSEcCtD
Atazanavir—Pruritus—Cyclosporine—systemic lupus erythematosus	4.17e-05	0.000418	CcSEcCtD
Atazanavir—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.17e-05	0.000417	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000417	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000415	CcSEcCtD
Atazanavir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.15e-05	0.000415	CcSEcCtD
Atazanavir—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.15e-05	0.000415	CcSEcCtD
Atazanavir—Convulsion—Prednisone—systemic lupus erythematosus	4.14e-05	0.000414	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.14e-05	0.000414	CcSEcCtD
Atazanavir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.13e-05	0.000413	CcSEcCtD
Atazanavir—Hypertension—Prednisone—systemic lupus erythematosus	4.13e-05	0.000413	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.000408	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.08e-05	0.000408	CcSEcCtD
Atazanavir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.07e-05	0.000407	CcSEcCtD
Atazanavir—Arthralgia—Prednisone—systemic lupus erythematosus	4.07e-05	0.000407	CcSEcCtD
Atazanavir—Myalgia—Prednisone—systemic lupus erythematosus	4.07e-05	0.000407	CcSEcCtD
Atazanavir—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.07e-05	0.000407	CcSEcCtD
Atazanavir—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.06e-05	0.000406	CcSEcCtD
Atazanavir—Anxiety—Prednisone—systemic lupus erythematosus	4.06e-05	0.000406	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—systemic lupus erythematosus	4.06e-05	0.000406	CcSEcCtD
Atazanavir—Insomnia—Dexamethasone—systemic lupus erythematosus	4.05e-05	0.000405	CcSEcCtD
Atazanavir—Insomnia—Betamethasone—systemic lupus erythematosus	4.05e-05	0.000405	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.04e-05	0.000404	CcSEcCtD
Atazanavir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.04e-05	0.000404	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.03e-05	0.000403	CcSEcCtD
Atazanavir—Discomfort—Prednisone—systemic lupus erythematosus	4.02e-05	0.000402	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—systemic lupus erythematosus	4.02e-05	0.000402	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—systemic lupus erythematosus	4e-05	0.0004	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.96e-05	0.000396	CcSEcCtD
Atazanavir—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.000394	CcSEcCtD
Atazanavir—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.94e-05	0.000394	CcSEcCtD
Atazanavir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.94e-05	0.000394	CcSEcCtD
Atazanavir—Urticaria—Triamcinolone—systemic lupus erythematosus	3.92e-05	0.000392	CcSEcCtD
Atazanavir—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.91e-05	0.000391	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000391	CcSEcCtD
Atazanavir—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.9e-05	0.00039	CcSEcCtD
Atazanavir—Dizziness—Cyclosporine—systemic lupus erythematosus	3.9e-05	0.00039	CcSEcCtD
Atazanavir—Oedema—Prednisone—systemic lupus erythematosus	3.9e-05	0.00039	CcSEcCtD
Atazanavir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.89e-05	0.00039	CcSEcCtD
Atazanavir—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.89e-05	0.00039	CcSEcCtD
Atazanavir—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.89e-05	0.00039	CcSEcCtD
Atazanavir—Infection—Prednisone—systemic lupus erythematosus	3.88e-05	0.000388	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.87e-05	0.000387	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.000387	CcSEcCtD
Atazanavir—Back pain—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000387	CcSEcCtD
Atazanavir—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000386	CcSEcCtD
Atazanavir—Fatigue—Betamethasone—systemic lupus erythematosus	3.86e-05	0.000386	CcSEcCtD
Atazanavir—Fatigue—Dexamethasone—systemic lupus erythematosus	3.86e-05	0.000386	CcSEcCtD
Atazanavir—Shock—Prednisone—systemic lupus erythematosus	3.84e-05	0.000384	CcSEcCtD
Atazanavir—Pain—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.000383	CcSEcCtD
Atazanavir—Pain—Betamethasone—systemic lupus erythematosus	3.83e-05	0.000383	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.83e-05	0.000383	CcSEcCtD
Atazanavir—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.81e-05	0.000381	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—systemic lupus erythematosus	3.79e-05	0.000379	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.77e-05	0.000377	CcSEcCtD
Atazanavir—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000376	CcSEcCtD
Atazanavir—Vomiting—Cyclosporine—systemic lupus erythematosus	3.75e-05	0.000375	CcSEcCtD
Atazanavir—Rash—Cyclosporine—systemic lupus erythematosus	3.72e-05	0.000372	CcSEcCtD
Atazanavir—Anorexia—Prednisone—systemic lupus erythematosus	3.72e-05	0.000372	CcSEcCtD
Atazanavir—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.72e-05	0.000372	CcSEcCtD
Atazanavir—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.71e-05	0.000371	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000371	CcSEcCtD
Atazanavir—Headache—Cyclosporine—systemic lupus erythematosus	3.7e-05	0.00037	CcSEcCtD
Atazanavir—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.69e-05	0.000369	CcSEcCtD
Atazanavir—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.69e-05	0.000369	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.66e-05	0.000366	CcSEcCtD
Atazanavir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.66e-05	0.000366	CcSEcCtD
Atazanavir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.66e-05	0.000366	CcSEcCtD
Atazanavir—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000364	CcSEcCtD
Atazanavir—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000363	CcSEcCtD
Atazanavir—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.63e-05	0.000363	CcSEcCtD
Atazanavir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.63e-05	0.000363	CcSEcCtD
Atazanavir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.61e-05	0.000361	CcSEcCtD
Atazanavir—Malaise—Methotrexate—systemic lupus erythematosus	3.6e-05	0.00036	CcSEcCtD
Atazanavir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.59e-05	0.000359	CcSEcCtD
Atazanavir—Urticaria—Betamethasone—systemic lupus erythematosus	3.56e-05	0.000356	CcSEcCtD
Atazanavir—Urticaria—Dexamethasone—systemic lupus erythematosus	3.56e-05	0.000356	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.55e-05	0.000356	CcSEcCtD
Atazanavir—Dizziness—Prednisolone—systemic lupus erythematosus	3.55e-05	0.000355	CcSEcCtD
Atazanavir—Asthenia—Triamcinolone—systemic lupus erythematosus	3.54e-05	0.000354	CcSEcCtD
Atazanavir—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000354	CcSEcCtD
Atazanavir—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000354	CcSEcCtD
Atazanavir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000354	CcSEcCtD
Atazanavir—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000354	CcSEcCtD
Atazanavir—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000354	CcSEcCtD
Atazanavir—Insomnia—Prednisone—systemic lupus erythematosus	3.53e-05	0.000353	CcSEcCtD
Atazanavir—Nausea—Cyclosporine—systemic lupus erythematosus	3.5e-05	0.000351	CcSEcCtD
Atazanavir—Pruritus—Triamcinolone—systemic lupus erythematosus	3.49e-05	0.000349	CcSEcCtD
Atazanavir—Cough—Methotrexate—systemic lupus erythematosus	3.49e-05	0.000349	CcSEcCtD
Atazanavir—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.49e-05	0.000349	CcSEcCtD
Atazanavir—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.47e-05	0.000347	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—systemic lupus erythematosus	3.46e-05	0.000346	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—systemic lupus erythematosus	3.43e-05	0.000344	CcSEcCtD
Atazanavir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.42e-05	0.000342	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—systemic lupus erythematosus	3.4e-05	0.00034	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—systemic lupus erythematosus	3.4e-05	0.00034	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—systemic lupus erythematosus	3.4e-05	0.00034	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—systemic lupus erythematosus	3.39e-05	0.000339	CcSEcCtD
Atazanavir—Rash—Prednisolone—systemic lupus erythematosus	3.39e-05	0.000339	CcSEcCtD
Atazanavir—Dermatitis—Prednisolone—systemic lupus erythematosus	3.38e-05	0.000338	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.38e-05	0.000338	CcSEcCtD
Atazanavir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.37e-05	0.000337	CcSEcCtD
Atazanavir—Fatigue—Prednisone—systemic lupus erythematosus	3.36e-05	0.000336	CcSEcCtD
Atazanavir—Headache—Prednisolone—systemic lupus erythematosus	3.36e-05	0.000336	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000336	CcSEcCtD
Atazanavir—Constipation—Prednisone—systemic lupus erythematosus	3.34e-05	0.000334	CcSEcCtD
Atazanavir—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.000333	CcSEcCtD
Atazanavir—Rash—Hydrocortisone—systemic lupus erythematosus	3.31e-05	0.000331	CcSEcCtD
Atazanavir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.3e-05	0.00033	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000329	CcSEcCtD
Atazanavir—Headache—Hydrocortisone—systemic lupus erythematosus	3.28e-05	0.000329	CcSEcCtD
Atazanavir—Dizziness—Triamcinolone—systemic lupus erythematosus	3.26e-05	0.000327	CcSEcCtD
Atazanavir—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.26e-05	0.000326	CcSEcCtD
Atazanavir—Infection—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000324	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.21e-05	0.000322	CcSEcCtD
Atazanavir—Asthenia—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000322	CcSEcCtD
Atazanavir—Asthenia—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000322	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.2e-05	0.00032	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.19e-05	0.000319	CcSEcCtD
Atazanavir—Nausea—Prednisolone—systemic lupus erythematosus	3.19e-05	0.000319	CcSEcCtD
Atazanavir—Pruritus—Betamethasone—systemic lupus erythematosus	3.17e-05	0.000317	CcSEcCtD
Atazanavir—Pruritus—Dexamethasone—systemic lupus erythematosus	3.17e-05	0.000317	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—systemic lupus erythematosus	3.17e-05	0.000317	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.15e-05	0.000315	CcSEcCtD
Atazanavir—Vomiting—Triamcinolone—systemic lupus erythematosus	3.14e-05	0.000314	CcSEcCtD
Atazanavir—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.13e-05	0.000313	CcSEcCtD
Atazanavir—Nausea—Hydrocortisone—systemic lupus erythematosus	3.11e-05	0.000312	CcSEcCtD
Atazanavir—Rash—Triamcinolone—systemic lupus erythematosus	3.11e-05	0.000311	CcSEcCtD
Atazanavir—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.11e-05	0.000311	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000311	CcSEcCtD
Atazanavir—Rash—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.000311	CcSEcCtD
Atazanavir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.1e-05	0.00031	CcSEcCtD
Atazanavir—Urticaria—Prednisone—systemic lupus erythematosus	3.1e-05	0.00031	CcSEcCtD
Atazanavir—Headache—Triamcinolone—systemic lupus erythematosus	3.09e-05	0.000309	CcSEcCtD
Atazanavir—Headache—Methylprednisolone—systemic lupus erythematosus	3.09e-05	0.000309	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—systemic lupus erythematosus	3.08e-05	0.000309	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—systemic lupus erythematosus	3.08e-05	0.000309	CcSEcCtD
Atazanavir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.07e-05	0.000307	CcSEcCtD
Atazanavir—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.07e-05	0.000307	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000297	CcSEcCtD
Atazanavir—Dizziness—Dexamethasone—systemic lupus erythematosus	2.96e-05	0.000296	CcSEcCtD
Atazanavir—Dizziness—Betamethasone—systemic lupus erythematosus	2.96e-05	0.000296	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—systemic lupus erythematosus	2.95e-05	0.000295	CcSEcCtD
Atazanavir—Nausea—Triamcinolone—systemic lupus erythematosus	2.93e-05	0.000293	CcSEcCtD
Atazanavir—Nausea—Methylprednisolone—systemic lupus erythematosus	2.93e-05	0.000293	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.91e-05	0.000291	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—systemic lupus erythematosus	2.9e-05	0.00029	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.87e-05	0.000288	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000287	CcSEcCtD
Atazanavir—Vomiting—Betamethasone—systemic lupus erythematosus	2.85e-05	0.000285	CcSEcCtD
Atazanavir—Vomiting—Dexamethasone—systemic lupus erythematosus	2.85e-05	0.000285	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.83e-05	0.000284	CcSEcCtD
Atazanavir—Rash—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000283	CcSEcCtD
Atazanavir—Rash—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000283	CcSEcCtD
Atazanavir—Dermatitis—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000282	CcSEcCtD
Atazanavir—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000282	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000282	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000281	CcSEcCtD
Atazanavir—Headache—Betamethasone—systemic lupus erythematosus	2.81e-05	0.000281	CcSEcCtD
Atazanavir—Headache—Dexamethasone—systemic lupus erythematosus	2.81e-05	0.000281	CcSEcCtD
Atazanavir—Asthenia—Prednisone—systemic lupus erythematosus	2.8e-05	0.00028	CcSEcCtD
Atazanavir—Pain—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000279	CcSEcCtD
Atazanavir—Pruritus—Prednisone—systemic lupus erythematosus	2.76e-05	0.000276	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.69e-05	0.000269	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—systemic lupus erythematosus	2.67e-05	0.000267	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000267	CcSEcCtD
Atazanavir—Nausea—Dexamethasone—systemic lupus erythematosus	2.66e-05	0.000266	CcSEcCtD
Atazanavir—Nausea—Betamethasone—systemic lupus erythematosus	2.66e-05	0.000266	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000259	CcSEcCtD
Atazanavir—Dizziness—Prednisone—systemic lupus erythematosus	2.58e-05	0.000258	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000258	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000258	CcSEcCtD
Atazanavir—Vomiting—Prednisone—systemic lupus erythematosus	2.48e-05	0.000248	CcSEcCtD
Atazanavir—Rash—Prednisone—systemic lupus erythematosus	2.46e-05	0.000246	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—systemic lupus erythematosus	2.46e-05	0.000246	CcSEcCtD
Atazanavir—Headache—Prednisone—systemic lupus erythematosus	2.44e-05	0.000244	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.4e-05	0.00024	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000234	CcSEcCtD
Atazanavir—Nausea—Prednisone—systemic lupus erythematosus	2.32e-05	0.000232	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000231	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.23e-05	0.000223	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000216	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000207	CcSEcCtD
Atazanavir—Rash—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000206	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—systemic lupus erythematosus	2.05e-05	0.000205	CcSEcCtD
Atazanavir—Headache—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000204	CcSEcCtD
Atazanavir—Nausea—Methotrexate—systemic lupus erythematosus	1.94e-05	0.000194	CcSEcCtD
